Report copyright - NEW Apoquel · Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther. In press. 2. Data on file. Study
Please pass captcha verification before submit form